vs
Perma-Pipe International Holdings, Inc.（PPIH）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Perma-Pipe International Holdings, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$61.1M vs $35.5M），Perma-Pipe International Holdings, Inc.净利率更高（10.3% vs -304.2%，领先314.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 47.1%），Perma-Pipe International Holdings, Inc.自由现金流更多（$12.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 23.4%）
Perma-Pipe International Holdings是一家专业研发、生产、销售预绝缘管道系统及一体化泄漏检测解决方案的企业，产品覆盖油气、区域冷暖、工业、市政基建等领域，业务遍布北美、中东、欧洲、亚洲等全球市场。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PPIH vs RXRX — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.1M | $35.5M |
| 净利润 | $6.3M | $-108.1M |
| 毛利率 | 34.4% | 59.8% |
| 营业利润率 | 18.6% | -304.8% |
| 净利率 | 10.3% | -304.2% |
| 营收同比 | 47.1% | 681.7% |
| 净利润同比 | 153.5% | 39.6% |
| 每股收益（稀释后） | $0.77 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $61.1M | $35.5M | ||
| Q3 25 | $47.9M | $5.2M | ||
| Q2 25 | $46.7M | $19.2M | ||
| Q1 25 | $45.0M | $14.7M | ||
| Q4 24 | $41.6M | $4.5M | ||
| Q3 24 | $37.5M | $26.1M | ||
| Q2 24 | $34.3M | $14.4M | ||
| Q1 24 | $40.2M | $13.8M |
| Q4 25 | $6.3M | $-108.1M | ||
| Q3 25 | $851.0K | $-162.3M | ||
| Q2 25 | $5.0M | $-171.9M | ||
| Q1 25 | $1.8M | $-202.5M | ||
| Q4 24 | $2.5M | $-178.9M | ||
| Q3 24 | $3.3M | $-95.8M | ||
| Q2 24 | $1.4M | $-97.5M | ||
| Q1 24 | $8.6M | $-91.4M |
| Q4 25 | 34.4% | 59.8% | ||
| Q3 25 | 30.1% | -183.8% | ||
| Q2 25 | 35.8% | -4.9% | ||
| Q1 25 | 33.7% | -48.0% | ||
| Q4 24 | 33.9% | -181.4% | ||
| Q3 24 | 35.9% | 53.7% | ||
| Q2 24 | 30.6% | 36.2% | ||
| Q1 24 | 30.0% | 19.1% |
| Q4 25 | 18.6% | -304.8% | ||
| Q3 25 | 6.7% | -3327.6% | ||
| Q2 25 | 16.9% | -916.8% | ||
| Q1 25 | 12.1% | -1297.9% | ||
| Q4 24 | 13.4% | -4042.4% | ||
| Q3 24 | 16.4% | -377.1% | ||
| Q2 24 | 9.1% | -697.4% | ||
| Q1 24 | 11.3% | -698.4% |
| Q4 25 | 10.3% | -304.2% | ||
| Q3 25 | 1.8% | -3135.3% | ||
| Q2 25 | 10.6% | -894.2% | ||
| Q1 25 | 3.9% | -1373.3% | ||
| Q4 24 | 6.0% | -3935.5% | ||
| Q3 24 | 8.8% | -367.5% | ||
| Q2 24 | 4.2% | -676.6% | ||
| Q1 24 | 21.5% | -662.4% |
| Q4 25 | $0.77 | $-0.17 | ||
| Q3 25 | $0.10 | $-0.36 | ||
| Q2 25 | $0.61 | $-0.41 | ||
| Q1 25 | $0.23 | $-0.50 | ||
| Q4 24 | $0.31 | $-0.56 | ||
| Q3 24 | $0.40 | $-0.34 | ||
| Q2 24 | $0.18 | $-0.40 | ||
| Q1 24 | $1.07 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $27.2M | $743.3M |
| 总债务越低越好 | $12.7M | $9.6M |
| 股东权益账面价值 | $85.8M | $1.1B |
| 总资产 | $217.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $27.2M | $743.3M | ||
| Q3 25 | $17.3M | $659.8M | ||
| Q2 25 | $18.8M | $525.1M | ||
| Q1 25 | $15.7M | $500.5M | ||
| Q4 24 | $13.3M | $594.4M | ||
| Q3 24 | $9.5M | $427.6M | ||
| Q2 24 | $7.7M | $474.3M | ||
| Q1 24 | $5.8M | $296.3M |
| Q4 25 | $12.7M | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | $15.2M | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | $15.2M | — |
| Q4 25 | $85.8M | $1.1B | ||
| Q3 25 | $80.2M | $1.0B | ||
| Q2 25 | $77.9M | $919.1M | ||
| Q1 25 | $72.1M | $933.9M | ||
| Q4 24 | $71.2M | $1.0B | ||
| Q3 24 | $68.6M | $524.6M | ||
| Q2 24 | $65.5M | $584.4M | ||
| Q1 24 | $65.7M | $401.2M |
| Q4 25 | $217.0M | $1.5B | ||
| Q3 25 | $189.0M | $1.4B | ||
| Q2 25 | $178.3M | $1.3B | ||
| Q1 25 | $165.2M | $1.3B | ||
| Q4 24 | $160.7M | $1.4B | ||
| Q3 24 | $157.8M | $726.5M | ||
| Q2 24 | $155.7M | $775.9M | ||
| Q1 24 | $155.7M | $557.8M |
| Q4 25 | 0.15× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | 0.21× | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 20.2% | -133.1% |
| 资本支出强度资本支出/营收 | 8.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.74× | — |
| 过去12个月自由现金流最近4个季度 | $12.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $17.3M | $-46.1M | ||
| Q3 25 | $-2.0M | $-117.4M | ||
| Q2 25 | $733.0K | $-76.4M | ||
| Q1 25 | $6.0M | $-132.0M | ||
| Q4 24 | $5.2M | $-115.4M | ||
| Q3 24 | $2.8M | $-59.2M | ||
| Q2 24 | $-73.0K | $-82.2M | ||
| Q1 24 | $7.1M | $-102.3M |
| Q4 25 | $12.4M | $-47.3M | ||
| Q3 25 | $-4.6M | $-117.6M | ||
| Q2 25 | $-194.0K | $-79.6M | ||
| Q1 25 | $4.7M | $-133.8M | ||
| Q4 24 | $4.8M | $-116.7M | ||
| Q3 24 | $2.2M | $-63.8M | ||
| Q2 24 | $-662.0K | $-83.4M | ||
| Q1 24 | $4.2M | $-109.0M |
| Q4 25 | 20.2% | -133.1% | ||
| Q3 25 | -9.6% | -2272.5% | ||
| Q2 25 | -0.4% | -413.9% | ||
| Q1 25 | 10.5% | -907.4% | ||
| Q4 24 | 11.6% | -2567.7% | ||
| Q3 24 | 5.8% | -244.6% | ||
| Q2 24 | -1.9% | -578.5% | ||
| Q1 24 | 10.5% | -789.9% |
| Q4 25 | 8.1% | 3.5% | ||
| Q3 25 | 5.3% | 4.7% | ||
| Q2 25 | 2.0% | 16.4% | ||
| Q1 25 | 2.9% | 12.4% | ||
| Q4 24 | 0.8% | 28.6% | ||
| Q3 24 | 1.7% | 17.5% | ||
| Q2 24 | 1.7% | 8.2% | ||
| Q1 24 | 7.2% | 48.2% |
| Q4 25 | 2.74× | — | ||
| Q3 25 | -2.40× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 3.42× | — | ||
| Q4 24 | 2.07× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | -0.05× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
